Documented concern based on cited evidence — not a personalized safety check, not medical advice, and not a decision to combine or avoid. That decision belongs with your prescriber.
Low-grade concern — timing, disclosure, or lab context
Low-grade documented concern. Timing, disclosure, or a lab context decides whether it matters for you.
Mechanism and evidence
Berberine inhibits CYP3A4 in vitro; mirtazapine is partly metabolized through CYP3A4, so blood levels of the antidepressant could shift. This is a metabolic flag, not a comment on mirtazapine effectiveness.
Evidence tier: mechanistic
The tier names the strongest cited study design. Some anchors studied the supplement on its own, or a related drug in the same class — in those pairs the grade rests on that evidence plus established pharmacology, as agreed with our medical reviewer.
What to discuss with your prescriber
- Tell your psychiatrist or GP if you take both.
- Do not change your mirtazapine dose on your own.